The latest thought leadership from our expert teams

Active filters (1)
Whitepaper

Generic inhalers: beyond reverse engineering

11th December 2018

Many of the dominant pharmaceutical companies operate partly, or wholly, in the generic drugs market. In 2016, the generics divisions of Teva, Mylan and Novartis all reported revenues in excess of $9bn with the top ten manufacturers...

  • Human factors
  • Industrial design
  • Mechanical engineering
  • Product realisation
  • Strategic advice
Opinion

Revolutionising clinical trials: creating a reliable and non-invasive stress monitoring system

28th November 2018

The rising cost of clinical trials (CTs), coupled with the commercial risks of failure, mean it’s increasingly important to harness the power of real-world data to inform effective trial designs, better understand outcomes and maximise the likelihood of clinical success...

  • Data science & analytics
  • Digital health
  • Machine learning & AI
  • Sensing
  • Signal processing
  • User Experience (UX)
Opinion

Next generation Elpenhaler® development

20th November 2018

Elpenhaler® is ELPEN’s propriety classic DPI device, developed to administer various medications for the treatment of asthma and COPD (Figure 1). Each dose of medication is packed into the blister of an alu-alu strip..

  • Human factors
  • Industrial design
  • Product realisation
  • User Experience (UX)
Whitepaper

Connected drug delivery devices: the reality of design and development

14th November 2018

Connected drug delivery products (Drug delivery devices with attached/incorporated capability that includes connectivity to wider digital services) continue to be a driving force in medical devices. In this whitepaper...

  • Digital health
  • Digital services
  • Machine learning & AI
  • Product realisation
  • Project management
  • Service design
  • Strategic advice
  • User Experience (UX)
Peer reviewed research

Adding Electronics to the Breezhaler®: Satisfying the Needs of Patients and Regulators

4th July 2018

Low adherence to therapy is a recognized issue in respiratory disease and has driven the development of electronic sensors for monitoring inhaler use. To date, sensors for dry powder inhalers (DPIs) have...

  • Connectivity & IoT
  • Digital health
  • Electronics & ASICs
  • Embedded software
  • Mechanical engineering
  • Sensing
Opinion

Technology, clinical trials and oncology - how they're all connected

9th May 2018

“What does the youngest chief executive in Big Pharma want? A control room straight off the starship Enterprise.”… That was the headline of a recent Forbes article on the vision of the new Novartis CEO, Vasant Narsimhan...

  • Digital health
  • Strategic advice
Whitepaper

Clinical trials: how technology is driving digitisation

23rd April 2018

The era of clinical trials as we’ve known them, is coming to an end. Rising costs, coupled with the commercial risks of failure, are unsustainable. This disruptive state is driving the adoption of new technologies, and catalysing...

  • Digital health
Infographic

Why digital technologies will disrupt clinical trials

16th April 2018

There is a need for more clinical trials across more sites. The need will continue to grow. This increase comes at a significant cost. Costs can be managed it we tack inefficiencies. digital technologies could reduce trial costs...

  • Digital health
Opinion

Finding bugs fast: microbial testing for cell and gene therapy

13th April 2018

I’ve just got back to the office from a very interesting workshop looking to address the challenge of delivering rapid microbial testing in cell and gene products...

  • Sensing
  • Synthetic biology
kite smart injection
Whitepaper

kite - smart insulin injection port concept

6th July 2017

kite is a smart insulin port concept designed to improve the insulin injection experience. It replaces 30-40 injections with a single weekly insertion and automatically sends dose capture data...

  • Digital health
Webinar

New FDA human factors guidelines

6th April 2017

The FDA’s draft guidelines on generics and interchangeable biosimilars have a huge effect on the way pharmaceuticals companies develop their generic and biosimilar products, satisfy the human factors...

  • Human factors
Whitepaper

Growth of connected medical devices & pharma

15th February 2017

The digital health revolution has been fuelled primarily by growing use of wearable and other consumer devices to gather various health metrics. Connected medical devices are not far behind.

  • Digital health